Skip to content
About Us
History
Leadership
Scientific Advisory Board
Collaboration and Partnership
Locations
Our Science
Small Molecules
ADC Platform
Pipeline
Small Molecules
Kinases
Encorafenib (BRAF)
Entrectinib (TRK, ROS)
Onvansertib (PLK1)
NMS-153 (MPS1)
NMS-812 (PERK/ GCN2)
Early Pipeline Projects
NAD+ Binding Family: PARP
NMS-293 (PARP1)
Atamparib (PARP7)
ADC Platform
Peptide Drug Conjugate (PDC)
Antibody Drug Conjugate (ADC)
Platform of Payload- Linkers
News/Events & Publications
News
Events
Publications
Careers
Contact Us
About Us
History
Leadership
Scientific Advisory Board
Collaboration and Partnership
Locations
Our Science
Small Molecules
ADC Platform
Pipeline
Small Molecules
Kinases
Encorafenib (BRAF)
Entrectinib (TRK, ROS)
Onvansertib (PLK1)
NMS-153 (MPS1)
NMS-812 (PERK/ GCN2)
Early Pipeline Projects
NAD+ Binding Family: PARP
NMS-293 (PARP1)
Atamparib (PARP7)
ADC Platform
Peptide Drug Conjugate (PDC)
Antibody Drug Conjugate (ADC)
Platform of Payload- Linkers
News/Events & Publications
News
Events
Publications
Careers
Contact Us
Search
3rd World Conference on Cancer biology and immunology
Home
/
News/Events & Publications
/ 3rd World Conference on Cancer biology and immunology
March 11-12
Milan, Italy
3
rd
World Conference on Cancer biology and immunology
Pre-clinical mouse models and breast cancer organoids reveal clues to therapeutic resistance and disease progression
6th CDDD Meeting computationally driven drug discovery
Share this page
Facebook
Twitter
LinkedIn
Email
svg.e-font-icon-svg {display:none!important} .elementor-button-icon {display:none!important} .show-more, .show-more2 {display:none!important}